14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CMRX ranks #12545 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$5.65 (-4.24%)

Volume: 1M

Closed: Dec 03, 2021

Hollow Logo Score: -3.025

Chimerix Stock Forecast

$5.65 (-4.24%)

Volume: 1M

Closed: Dec 03, 2021

Score Hollow Logo -3.025
Which way will CMRX go? Request
Key Stats
P/E Ratio -3.38
Beta 1.7
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 42 and the stock is currently not being overbought or oversold

Chimerix stock price down 4.24% on Friday
(Updated on Dec 03, 2021)

Sell candidate since 2021-12-01 Loss -3.75%

The Chimerix stock price fell by -4.24% on the last day (Friday, 3rd Dec 2021) from $5.90 to $5.65. During the day the stock fluctuated 9.52% from a day low at $5.57 to a day high of $6.10. The price has fallen in 5 of the last 10 days and is down by -11.02% for this period. Volume has increased on the last day by 510 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $8.14 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.89% during the next 3 months and, with a 90% probability hold a price between $4.38 and $5.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Chimerix stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $5.96 and $5.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, November 18, 2021, and so far it has fallen -11.02%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Chimerix finds support from accumulated volume at $5.59 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.53 between high and low, or 9.52%. For the last week, the stock has had a daily average volatility of 8.78%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Chimerix stock A Buy?

Chimerix holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.025

Predicted Opening Price for Chimerix of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$5.77 $5.65 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 22, 2021 "HC Wainwright" gave "$19.00 - $21.00" rating for CMRX. The price target was set to $6.07+1.5%.

Volatility and Risk
Daily Average Volatility: 8.78 %
Overall Risk: Very High High Medium Low Very Low
8.78 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $6.10
Price: $5.65
Support: $5.59

CMRX Insider Trading Show all Trades



Last 100 transactions
Buy: 6 968 193 | Sell: 6 626 980 (Shares)
Date Action Amount Person Type
Sep 30, 2021 Sell 4 590 Jakeman David Common Stock
Sep 14, 2021 Sell 6 500 000 Cantex Pharmaceuticals, Inc. Common Stock, par value $0.001
Jun 28, 2021 Buy 6 950 Middleton Fred A Common Stock
Jun 25, 2021 Buy 3 050 Middleton Fred A Common Stock
Jun 23, 2021 Buy 35 000 Gilliss Catherine Stock Option (Right to Buy)
Show all Insider Trades


Last 100 transactions
Buy: 6 968 193 | Sell: 6 626 980 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 6.30 11.56 %
6.10 7.98 %
5.98 5.77 %
Current price: 5.65
Support 5.57 -1.40 %
5.45 -3.61 %
5.24 -7.20 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 6.35 12.39 %
6.27 10.97 %
6.10 7.96 %
Current price 5.65
Support 5.59 -1.06%
5.33 -5.66%
5.25 -7.08%

Click to get the best stock tips daily for free!

About Chimerix

Chimerix Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals in the areas of unmet medical needs in the United States. The company’s lead product candidate is brincidofovir (CMX001), a nucleotide analog, which is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adeno... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE